🔬Mark Broenstrup and Vivek K. Mishra (Ph.D.) from Helmholtz-Zentrum für Infektionsforschung working on the optimization of an AMP-inducer molecule by medicinal chemistry.
Brunswick, Germany, October, 2024. 🧪
MaxImmun, Mark Broenstrup, Vivek K. Mishra (Ph.D.), Dan Andersson, Nathalie Vergnolle, Al-Mourabit Ali, Sylvain PETEK, Laurent de Crasto, Brice Sperandio, PhD
MaxImmun is a Horizon Europe project supported by the European Union, through the European Innovation Council
Grant agreement N°101129622
Start date : January 1, 2024
Duration : 48 months
An innovative therapeutic strategy to fight bacterial antibioresistance. Stay updated with the latest breakthroughs by joining our newsletter.
